Details for New Drug Application (NDA): 021228
✉ Email this page to a colleague
NDA 021228 describes DETROL LA, which is a drug marketed by Upjohn and is included in one NDA. Additional details are available on the DETROL LA profile page.
The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 021228
| Tradename: | DETROL LA |
| Applicant: | Upjohn |
| Ingredient: | tolterodine tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021228
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 2MG | ||||
| Approval Date: | Dec 22, 2000 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 4MG | ||||
| Approval Date: | Dec 22, 2000 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
